Every year, pneumonia kills more young children than any other infectious disease—and the standard treatment in low-income countries may no longer be working well enough. The problem is twofold. First, many clinicians in places like Kenya already doubt that the World Health Organization’s recommended antibiotics—benzylpenicillin plus gentamicin—are effective, especially after widespread vaccination changed which germs cause pneumonia. Second, severely ill children need fluids and nutrition, but there is no clear evidence on whether feeding through a nasogastric tube is safer and more nourishing than giving fluids through an intravenous drip, which requires scarce nursing time and lacks calories. This trial will recruit 4,392 children across 12 Kenyan hospitals. Each child will receive one of three antibiotic regimens and either tube feeding or intravenous fluids. The researchers will compare death rates within five days, hospital stays, and 30-day survival. They will also analyse chest X-rays and blood samples to understand why some treatments work better, and assess costs and caregivers’ views. If the study finds that alternative antibiotics or tube feeding reduce deaths, it could directly change WHO treatment guidelines and save thousands of children’s lives each year in low-resource settings.
View original technical description
Pneumonia, an infection of the lungs, is the leading cause of deaths among young children. The World Health Organization (WHO) have developed recommendations for the diagnosis and treatment of pneumonia in low and middle income countries using simple clinical features and low cost, widely available antibiotics. The recommend treatment for children at the highest risk of death (severe pneumonia) is injectable benzylpenicillin or ampicillin and gentamicin. Following the introduction of vaccines against the main causes of pneumonia to national immunization programmes in many low-income countries, there has been growing debate over the appropriateness of the currently recommended treatments. Many clinicians already believe that the recommended treatment is ineffective and frequently opt to use other antibiotics such as amoxicillin-clavulanic acid and ceftriaxone instead. The first key question in this study seeks to compare two antibiotics against the current recommended treatment. We will investigate is whether either (i) intravenous amoxicillin-clavulanic acid or (ii) ceftriaxone is superior to benzylpenicillin plus gentamicin (standard care) for the treatment of children admitted to hospital with severe pneumonia. Some authorities advise against feeding through a tube inserted into the stomach through the nose in severely ill children. The main reason for this is are the potential for compromising the ability to breath in a patient already experiencing difficulty breathing and an increased risk of choking on feeds given through the tube. However, the alternative, providing fluids through an intravenous drip requires careful monitoring by a nurse to ensure the fluid is given at a safe rate over the desired duration. This a common challenge in many low resource settings where a limited number of nursing staff are required to attend to several duties. Fluids provided through a drip are also lack the necessary nutrients to match the increased demands of the body during a serious illness. The second key question for this study is therefore whether feeding through a tube inserted into the stomach through the nose is superior to providing fluids through an intravenous drip for the management of children with severe pneumonia. We will recruit 4392 children at 12 hospitals in Kenya. Children who meet the criteria for recruitment will be allocated to the study treatment groups through a balanced process pre-determined process that ensures each participant has a fair chance of receiving any given study treatments. Each of the two questions will be studied in the same set of patients. Thus, a child recruited in the study will receive any one of the three antibiotic treatments and either of the two fluid treatments. For each of the study questions, we will compare the percentage of children who die within the first five day of recruitment in the alternative treatment groups. We will also compare the length of hospitalisation, and the percentage of children who die within 30 days of recruitment in the alternative treatment groups. Chest X-rays and blood samples will be collected in a smaller group of patients to examine possible explanations for differences in responses to the treatments. Finally, we will compare the costs of receiving the alternative study treatments against the outcomes we observe among children assigned to the respective study groups and explore the social perceptions of caregivers and health workers towards the treatments.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know